Cobalt Policy Adopted by Regulators: Horseracingnation.com 4/27/15

RMTC Press Release The Association of Racing Commissioners International (RCI) is formally notifying regulators and their testing labs of a new policy that would make it illegal to administer cobalt to a race horse. The RCI Board of Directors last week voted to sanction trainers of horses that were found to have a cobalt level

Broad Horse-Protection Plan Floated by RCI: The Blood-Horse 4/23/15

RMTC By Tom LaMarra The Association of Racing Commissioners International will put out for comment a broad equine welfare proposal that would sanction anyone found to have used excessive amounts of substances to the detriment of racehorses. The proposal was introduced by Rick Goodell, executive director of the New York State Gaming Commission, during the

RCI Board Approves Cobalt Regulations: The Blood-Horse 4/23/15

RMTC By Tom LaMarra The Association of Racing Commissioners International board of directors April 23 approved a testing threshold level and penalties for the mineral cobalt, a naturally occurring substance in racehorses. During a meeting in Tampa, Fla., the RCI Drug Testing Standards and Practices Committee took testimony from the Racing Medication and Testing Consortium

Broad Horse-Protection Plan Floated by RCI: The Blood-Horse 4/23/15

RMTC By Tom LaMarra The Association of Racing Commissioners International will put out for comment a broad equine welfare proposal that would sanction anyone found to have used excessive amounts of substances to the detriment of racehorses. The proposal was introduced by Rick Goodell, executive director of the New York State Gaming Commission, during the

RMTC Makes Therapeutic Withdrawal Time Recommendations, Announces Progress of its Drug… 10/20/10

NEWS RELEASE October 20, 2010 Contact: Hallie Lewis (859) 224-2848 RMTC MAKES THERAPEUTIC WITHDRAWAL TIME RECOMMENDATIONS, ANNOUNCES PROGRESS OF ITS DRUG TESTING INITIATIVES TASK FORCE Based on the recommendation of its Scientific Advisory Committee, the Racing Medication and Testing Consortium (RMTC) board of directors has recommended scientifically identified withdrawal guidelines and plasma thresholds for the